Roche Holding Ltd · SIX:RO

Roche — Fact Sheet (July 2020)

2 slides from Roche's fact sheet, July 2020

  1. Slide 1: Immunoassay for the qualitative detection of antibodies against SARS-CoV-2

    Ordering information Product Material configuration Material number Elecsys ® Anti-SARS-CoV-2 a) 200 tests 09 203 095 190 Elecsys ® Anti-SARS-CoV-2 b) 300 tests 09 203 079 190 PreciControl Anti-SARS-CoV-2 4 × 1.0 mL 09 216 928 190 Diluent MultiAssay* a) 2 × 16 mL 03 609 987 190 Diluent MultiAssay* b

  2. Slide 2: Elecsys Anti-SARS-CoV-2 assay characteristics and clinical specificity

    Upon infection with SARS-CoV-2, the host mounts an immune maturation36. High-affinity antibodies can elicit neutralization by Elecsys® Anti-SARS-CoV-2 assay characteristics Analytical specificity45 response against the virus, including production of specific recognizing and binding specific viral ep

Roche Holding — Fact Sheet (July 2020) on 6ix